Scientists test genetically 'Fixed' skin to heal devastating blisters
NCT ID NCT04186650
Summary
This early-stage trial is testing a new gene therapy approach for a severe, inherited skin-blistering disease called Recessive Dystrophic Epidermolysis Bullosa (RDEB). Doctors take a small sample of a patient's own skin cells, correct the genetic flaw in a lab, grow new skin sheets, and graft them back onto the patient's wounds. The main goal is to see if this process is safe and if the new, corrected skin heals properly and is more resistant to blistering.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA, RECESSIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Imagine Necker Hospital
Paris, 75743, France
Conditions
Explore the condition pages connected to this study.